Theme Templates,  —

Recent Posts

• Arbaclofen Improved Behavior of Almost Half of Children in Phase 3 Trial
• Tracking Signaling Pathway Activity May Be Biomarker in Testing Anavex2-73
• Gene Therapy Appears to Improve Behavioral Symptoms in Fragile X Mice
• Three Clinical Trials Will Continue to Assess Effectiveness of BPN14770 in Fragile X
• Lenire to Develop Oral Therapy for Fragile X Under New License Agreement
• Fragile X Awareness Day Set to Take International Stage July 22
• List of Rare Diseases Tops 10,000 – and Is Growing – New Analysis Finds
• Nova Mentis Partners With UCF to Develop Saliva Test for Serotonin
• Zygel Cannabidiol Gel Still Found Effective for Children in Interim Analysis
• Approval Advances Psilocybin Treatment Plans in Canada